The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The MicroRNA Market Between 2026 And 2030?
The microrna market size has experienced significant expansion in recent years. Its valuation is projected to increase from $1.57 billion in 2025 to $1.86 billion in 2026, reflecting a compound annual growth rate (CAGR) of 18.5%. The historical growth of this market can be linked to the increased embrace of genomic research, a growing demand for biomarker discovery, the development of PCR-based testing, the broadening of cancer research initiatives, and the escalating use of NGS instruments.
The microrna market is projected for significant expansion in the coming years, reaching $3.32 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.6%. This growth during the forecast period is fueled by several factors, including the expanding clinical uses of microrna diagnostics, the increasing adoption of personalized medicine, advancements in therapeutic microrna development, broadened infectious disease research, and growing investments in molecular assay technologies. Key trends anticipated over the forecast period encompass the broadening scope of precision genomics, AI-powered microrna expression analysis, increased reliance on cloud-based sequencing data storage, enhanced automation in molecular diagnostics, and the integration of IoT for streamlined laboratory workflows.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp
What Major Drivers Are Influencing Demand In The MicroRNA Market?
The expanding incidence of cancer is projected to fuel the advancement of the microRNA market in the future. Cancer is defined as an intricate illness marked by unregulated cell multiplication and growth, frequently resulting in the development of malignant tumors capable of infiltrating nearby tissues and metastasizing to remote organs, thereby presenting considerable health dangers. The rising occurrence of cancer diagnoses stems from multiple elements, such as an aging demographic, lifestyle decisions like smoking and unhealthy eating, environmental contaminants, and enhanced screening techniques that facilitate earlier detection. MicroRNA is integrated with conventional cancer treatments to boost drug responsiveness and better patient results. Furthermore, beyond therapeutic applications, miRNAs function as diagnostic and prognostic indicators, assisting in the classification of cancer types, forecasting disease advancement, and tracking responses to therapy. For example, data from May 2024, provided by the National Cancer Institute, a government body based in the US, revealed approximately 20 million new cases and 9.7 million cancer-associated fatalities annually in 2022, with forecasts suggesting 15.3 million deaths and 29.9 million new cases per year by 2040. Consequently, the growing prevalence of cancer cases is fueling the expansion of the microRNA market.
Which Market Segments Are Examined In The MicroRNA Market Study?
The microrna market covered in this report is segmented –
1) By Product: Instruments, Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing, MiRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications
4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations
Subsegments:
1) By Instruments: Quantitative PCR Systems, Microarray Platforms, Next-Generation Sequencing (NGS) Systems, Real-Time PCR Instruments, Microrna Analyzers
2) By Consumables: MicroRNA Kits ( Extraction Kits, Detection Kits), PCR Reagents, Primers And Probes, Microarrays And Chips, RNA Sequencing Kits
How Are Trends Impacting The MicroRNA Market?
Leading companies within the microRNA market are concentrating on developing sophisticated solutions, such as miRNA probe customization services, to address the distinct requirements of researchers and clinicians, enhance the precision of miRNA detection, and enable a broad spectrum of applications. MiRNA probe customization services denote specialized offerings from biotechnology and molecular biology companies that involve designing and manufacturing bespoke probes specific to particular microRNAs (miRNAs) for diverse research and clinical uses. For example, in September 2023, Abnova Corporation, a Taiwan-based biotech company, introduced improved services for customizing miRNA probes, along with a new collection of cataloged miRNA probes, to cater to the varied needs of academic, industrial, and research communities engaged in miRNA investigations. These probes are instrumental in identifying and accurately locating miRNAs, which are small, non-coding RNA molecules vital for various biological processes. Abnova’s customization services ensure high specificity and minimal cross-reactivity, making them particularly suitable for analyzing samples containing limited miRNA content.
Who Are The Primary Competitors In The MicroRNA Market?
Major companies operating in the microrna market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc.
Read the full microrna market report here:
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report
Which Region Shows The Strongest Potential For Future Growth In The MicroRNA Market?
North America was the largest region in the microRNA market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microrna market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored MicroRNA Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15608&type=smp
Browse Through More Reports Similar to the Global MicroRNA Market 2026, By The Business Research Company
Organic Skincare Global Market Report
https://www.thebusinessresearchcompany.com/report/organic-skincare-global-market-report
Professional Skincare Global Market Report
https://www.thebusinessresearchcompany.com/report/professional-skincare-global-market-report
Skin Care Products Global Market Report
https://www.thebusinessresearchcompany.com/report/skin-care-products-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model